Adlai Nortye Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANL research report →
About the company
Adlai Nortye Ltd. (ANL) is a clinical-stage biotechnology firm dedicated to the research and development of innovative pharmaceutical products. Their flagship compound, AN2025, a pan-phosphoinositide 3-kinase inhibitor, is currently undergoing Phase III clinical trials.
- CEO
- Yang Lu
- IPO
- 2023
- Employees
- 123
- HQ
- Grand Cayman, KY
Price Chart
- Market Cap
- $503.73M
- P/E
- -2.85
- P/S
- 100.75
- P/B
- -12.15
- EV/EBITDA
- -15.52
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -713.96%
- Net Margin
- -710.56%
- ROE
- -414.01%
- ROIC
- -197.73%
- Revenue
- $5.00M · 0.00%
- Net Income
- $-35,528,000 · 31.50%
- EPS
- $-3.33 · 31.90%
- Op Income
- $-35,698,000
- FCF YoY
- 35.13%
- 52W High
- $17.25
- 52W Low
- $0.88
- 50D MA
- $12.02
- 200D MA
- $6.49
- Beta
- 0.99
- Avg Volume
- 342.94K
Get TickerSpark's AI analysis on ANL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Ji Ping | other | 136,667 |
| May 28, 26 | Ye Xiaofeng | other | 0 |
| May 28, 26 | Ye Xiaofeng | other | 0 |
| Nov 1, 20 | Ye Xiaofeng | other | 2,584 |
| Sep 8, 20 | Ye Xiaofeng | other | 66,667 |
| Apr 1, 22 | Ye Xiaofeng | other | 25,000 |
| Mar 18, 26 | Tse Alan Ming Lun | other | 0 |
| May 13, 26 | LU YANG | sell | 10 |
| Mar 18, 26 | LU YANG | other | 0 |
| Mar 18, 26 | LU YANG | other | 0 |
Our ANL coverage
Recent articles, reports, and earnings notes.
No research on ANL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANL report →Similar companies
Peers in the same neighborhood.